Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-02T18:47:35.608Z Has data issue: false hasContentIssue false
  • English
  • Français

The role of serotonin in panic: evidence from tryptophan depletion studies

Published online by Cambridge University Press:  24 June 2014

A. C. Pyle ,
S. V. Argyropoulos  and
D. J. Nutt
Get access Rights & Permissions [Opens in a new window]

Abstract

There has been growing interest in the role of serotonin (5-hydroxytryptamine, 5-HT) in anxiety, including pathological states such as panic disorder. The technique of tryptophan depletion (TD), which causes an acute, temporary and reversible reduction in brain 5-HT levels, is a useful minimally invasive paradigm to aid the research of the role of 5-HT in various disorders. This review discusses the evidence supporting the hypothesis that 5-HT function is of importance in the neurobiology of panic disorder and considers in more detail how our understanding has been influenced by work using the technique of TD. Possible avenues for future research are also discussed.

Keywords

panicserotonintrytophan depletion
Type
Review Article
Information
Acta Neuropsychiatrica , Volume 16 , Issue 2 , April 2004 , pp. 79 - 84
Copyright
Copyright © 2004 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bell, CJ, Nutt, DJ. Serotonin and panic. Br J Psychiatry 1998;172: 465–471.CrossRefGoogle ScholarPubMed
Deakin, JF, Graeff, F. 5-HT and mechanisms of defence. J Psychopharmacol 1991;5: 305–315. CrossRefGoogle ScholarPubMed
Nutt, DJ, Glue, P. Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective. Pharmacol Ther 1989;44: 309–334.CrossRefGoogle ScholarPubMed
Handley, SL, McBlane, JW, Critchley, MA, Njung, EK. Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors. Behav Brain Res 1993;58: 203–210.CrossRefGoogle ScholarPubMed
Den Boer, JA, Westenberg, HG. Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology (Berl) 1990;102: 85–94.CrossRefGoogle ScholarPubMed
Den Boer, JA. Pharmacotherapy of panic disorder: differential efficacy from a clinical viewpoint. J Clin Psychiatry 1998;59(Suppl. 8):30–36. Google ScholarPubMed
Valenca, AM, Nardi, AE, Nascimento, I, Mezzasalma, MA, Lopes, FL, Zin, W. Double-blind clonazepam vs placebo in panic disorder treatment. Arq Neuropsiquiatr 2000; 58: 1025–1029.CrossRefGoogle ScholarPubMed
Argyropoulos, SV, Sandford, JJ, Nutt, DJ. The psychobiology of anxiolytic drug. Part 2. Pharmacological treatments of anxiety. Pharmacol Ther 2000;88: 213–227.CrossRefGoogle ScholarPubMed
Kasper, S, Resinger, E. Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors. Eur Neuropsychopharmacol 2001;11: 307–321.CrossRefGoogle ScholarPubMed
Boyer, W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 1995;10: 45–49.CrossRefGoogle ScholarPubMed
Nutt, DJ, Cowen, PJ. Benzodiazepine–serotonin interactions in man. Psychopharmacol Series 1987;3: 72–76. Google ScholarPubMed
Tork, I. Anatomy of the serotonergic system. Ann NY Acad Sci 1990;600: 9–34.CrossRefGoogle ScholarPubMed
Pike, VW, McCarron, JA, Lammerstma, AAet al. First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635. Eur J Pharmacol 1995; 283: R1–R3.CrossRefGoogle Scholar
Tauscher, J, Bagby, RM, Javanmard, M, Christensen, BK, Kasper, S, Kapur, S. Inverse relationship between serotonin 5-HT (1A) receptor binding and anxiety: a [(11) C]WAY-100635 PET investigation in healthy volunteers. Am J Psychiatry 2001;158: 1326–1328.CrossRefGoogle Scholar
Menkes, DB, Coates, DC, Fawcett, JP. Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord 1994;32: 37–44.CrossRefGoogle ScholarPubMed
Weltzin, TE, Fernstrom, JD, McConaha, C, Kaye, WH. Acute tryptophan depletion in bulimia: effects on large neutral amino acids. Biol Psychiatry 1994;35: 388–397.CrossRefGoogle ScholarPubMed
Wurtman, RJ, Hefti, F, Melamed, E. Precursor control of neurotransmitter synthesis. Pharmacol Rev 1980; 32: 315–335.Google ScholarPubMed
Shopsin, B, Gershon, S, Goldstein, M, Friedman, E, Wilk, S. Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmacol Commun 1975;1: 239–249.Google ScholarPubMed
Delgado, PL, Charney, DS, Price, LH, Landis, H, Heninger, GR. Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. Life Sci 1989;45: 2323–2332.CrossRefGoogle ScholarPubMed
Delgado, PL, Charney, DS, Price, LH, Aghajanian, GK, Landis, H, Heninger, GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch General Psychiatry 1990;47: 411–418. CrossRefGoogle ScholarPubMed
Miller, HL, Delgado, PL, Salomon, RM, Licinio, J, Barr, LC, Charney, DS. Acute tryptophan depletion: a method of studying antidepressant action. J Clin Psychiatry 1992;53(Suppl. ):28–35.Google ScholarPubMed
Carpenter, LL, Anderson, GM, Pelton, Ghet al. Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 1998;19: 26–35.CrossRefGoogle ScholarPubMed
Williams, WA, Shoaf, SE, Hommer, D, Rawlings, R, Linnoila, M. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J Neurochem 1999;72: 1641–1647.CrossRefGoogle ScholarPubMed
Delgado, PL, Miller, HL, Salomon, RMet al. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry 1999;46: 212–220.CrossRefGoogle ScholarPubMed
Aberg-Wistedt, A, Hasselmark, L, Stain-Malmgren, R, Aperia, B, Kjellman, BF, Mathe, AA. Serotonergic ‘vulnerability’ in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders. Acta Psychiatr Scand 1998;97: 374–380.CrossRefGoogle ScholarPubMed
Delgado, PL, Charney, DS, Price, LH, Aghajanian, GK, Landis, H, Heninger, GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch General Psychiatry 1990;47: 411–418. CrossRefGoogle ScholarPubMed
Bell, C, Abrams, J, Nutt, D. Tryptophan depletion and its implications for psychiatry. Br J Psychiatry 2001;178: 399–405.CrossRefGoogle ScholarPubMed
Miller, HE, Deakin, JF, Anderson, IM. Effect of acute tryptophan depletion on CO2-induced anxiety in patients with panic disorder and normal volunteers. Br J Psychiatry 2000;176: 182–188.CrossRefGoogle ScholarPubMed
Klaassen, T, Klumperbeek, J, Deutz, NE, Van Praag, HM, Griez, E. Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge. Psychiatry Res 1998;77: 167–174.CrossRefGoogle ScholarPubMed
Koszycki, D, Zacharko, RM, Le Melledo, JM, Young, SN, Bradwejn, J. Effect of acute tryptophan depletion on behavioral, cardiovascular, and hormonal sensitivity to cholecystokinin-tetrapeptide challenge in healthy volunteers. Biol Psychiatry 1996;40: 648–655.CrossRefGoogle ScholarPubMed
Kent, JM, Coplan, JD, Martinez, J, Karmally, W, Papp, LA, Gorman, JM. Ventilatory effects of tryptophan depletion in panic disorder: a preliminary report. Psychiatry Res 1996;64: 83–90.CrossRefGoogle ScholarPubMed
Goddard, AW, Charney, DS, Germine, Met al. Effects of tryptophan depletion on responses to yohimbine in healthy human subjects. Biol Psychiatry 1995;38: 74–85.CrossRefGoogle ScholarPubMed
Schruers, K, Klaassen, T, Pols, H, Overbeek, T, Deutz, NE, Griez, E. Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients. Psychiatry Res 2000;93: 179–187.CrossRefGoogle ScholarPubMed
Goddard, AW, Sholomskas, DE, Walton, KEet al. Effects of tryptophan depletion in panic disorder. Biol Psychiatry 1994;36: 775–777.CrossRefGoogle ScholarPubMed
Bell, C, Forshall, S, Adrover, Met al. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. J Psychopharmacol 2002;16: 5–14.CrossRefGoogle Scholar
Nutt, DJ, Glue, P, Lawson, C, Wilson, S. Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch General Psychiatry 1990;47: 917–925. CrossRefGoogle ScholarPubMed
Clark, DM, Salkovskis, PM, Hackmann, A, Middleton, H, Anastasiades, P, Gelder, M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 1994;164: 759–769.CrossRefGoogle ScholarPubMed
Barlow, DH, Gorman, JM, Shear, MK, Woods, SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. J Am Med Assoc 2000;283: 2529–2536. CrossRefGoogle ScholarPubMed
Beck, JG, Stanley, MA, Baldwin, LE, Deagle, EA III, , Averill, PM. Comparison of cognitive therapy and relaxation training for panic disorder. J Consult Clin Psychol 1994;62: 818–826.CrossRefGoogle ScholarPubMed
Neumeister, A, Konstantinidis, A, Stastny, Jet al. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch General Psychiatry 2002;59: 613–620. CrossRefGoogle ScholarPubMed